Adjuvant therapy for cutaneous melanoma.
作者信息
Nathan F E, Mastrangelo M J
机构信息
Department of Medicine, Jefferson Medical College, Philadelphia, PA 19107, USA.
出版信息
Semin Oncol. 1995 Dec;22(6):647-61.
PMID:8539640
Abstract
摘要
相似文献
1
Adjuvant therapy for cutaneous melanoma.皮肤黑色素瘤的辅助治疗
Semin Oncol. 1995 Dec;22(6):647-61.
2
Phase III adjuvant studies in operable malignant melanoma (review).可手术恶性黑色素瘤的III期辅助性研究（综述）
Anticancer Res. 1987 Jul-Aug;7(4B):701-5.
3
[Guidelines for clinical practice: Standards, Options and Recommendations 2005 for the management of adult patients exhibiting an M0 cutaneous melanoma, full report. National Federation of Cancer Campaign Centers. French Dermatology Society. Update of the 1995 Consensus Conference and the 1998 Standards, Options, and Recommendations].[临床实践指南：2005年成人M0皮肤黑色素瘤管理的标准、选项和建议，完整报告。全国癌症防治中心联合会。法国皮肤病学会。1995年共识会议及1998年标准、选项和建议的更新]
Ann Dermatol Venereol. 2005 Dec;132(12 Pt 2):10S3-10S85.
4
[To outwit melanoma with its own tricks].用黑色素瘤自身的 tricks 来智取它
MMW Fortschr Med. 2003 Apr 10;145(15):4-6, 8, 10.
5
Adjuvant interferon therapy for melanoma: high-dose, low-dose, no dose, which dose?黑色素瘤的辅助干扰素治疗：高剂量、低剂量、不使用剂量，究竟该用哪种剂量？
J Clin Oncol. 2004 Jan 1;22(1):7-10. doi: 10.1200/JCO.2004.10.907. Epub 2003 Dec 9.
6
Melanoma and immunotherapy.黑色素瘤与免疫疗法
Hematol Oncol Clin North Am. 2009 Jun;23(3):547-64, ix-x. doi: 10.1016/j.hoc.2009.03.009.
7
The treatment of malignant melanoma.恶性黑色素瘤的治疗。
Eur J Surg Oncol. 1985 Jun;11(2):111-5.
8
Adjuvant interferon in melanoma - a resurrection?黑色素瘤中的辅助性干扰素——重获新生？
Br J Cancer. 2001 May 4;84(9):1141-2. doi: 10.1054/bjoc.2001.1798.
9
Present status and future prospects for adjuvant therapy of melanoma: time to build upon the foundation of high-dose interferon alfa-2b.黑色素瘤辅助治疗的现状与未来展望：是时候在高剂量干扰素α-2b的基础上更进一步了。
J Clin Oncol. 2004 Jan 1;22(1):11-4. doi: 10.1200/JCO.2004.10.952. Epub 2003 Dec 9.
10
[Present concepts of the treatment of malignant melanoma (author's transl)].
Acta Chir Belg. 1975 Jul;74(4):395-405.
Zotero 插件